NPCE — Neuropace Inc
NASDAQ · Healthcare · Medical Devices
$15.10
+$0.36 (+2.41%)
Neuropace Inc (NPCE) is a medical devices company listed on NASDAQ. It is led by Joel D. Becker, based in 455 North Bernardo Avenue, Mountain View, CA, United States, 94043, with about 195 employees. NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Latest reported NPCE revenue for 2025-09-30 was $27.4M. Net income was -$3.5M. Revenue was up 16.3% from 2025-06-30 to 2025-09-30. NPCE currently screens at market cap $312.2M.
Use this NPCE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NPCE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NPCE SEC filings page. Lician reads the product cache first so this HTML stays unique to Neuropace Inc even when a live quote feed is slow.
About Neuropace Inc
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
NPCE Key Statistics
Market Cap
$312.24M
Volume
151,826
Previous Close
$13.99
Day Range
$13.97 – $14.27
EPS
-$0.93
Revenue
$79.91M
Net Income
-$27.14M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+22.1%
Profit Margin
-34.0%
Employees
195
NPCE Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $79.91M | $65.42M | $45.52M | $45.18M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$27.14M | -$32.96M | -$47.08M | -$36.08M |
| EPS (Diluted) | -$0.93 | -$1.27 | -$1.91 | -$2.17 |
Total Assets
$94.65M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$13.43M
Operating Cash Flow
-$17.95M
Free Cash Flow
$0.00
Neuropace Inc Company Information
- CEO, President & Director
- Joel D. Becker
- Headquarters
- 455 North Bernardo Avenue, Mountain View, CA, United States, 94043
- Website
- www.neuropace.com
- Phone
- (650) 237-2700
- IPO / Founded
- 2021-04-22
- Sector
- Healthcare
- Industry
- Medical Devices